SCHEMBL22985774

SCHEMBL22985774

CSB(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10356515 0.67
SCHEMBL313893 0.65
SCHEMBL15576727 0.65
SCHEMBL15450866 0.63
SCHEMBL23759947 0.60
SCHEMBL19650474 0.60
SCHEMBL18531821 0.60
SCHEMBL21301176 0.60
SCHEMBL14950512 0.60
SCHEMBL2126835 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220236294-A1 Methods for Evaluation and Treatment of Alzheimer's Disease and Applications Thereof HUNTINGTON MEDICAL RESEARCH INSTITUTES (US) 2022-07-28 US disclosed
US-11345725-B2 Bis-thioether stapled peptides as inhibitors of PRC2 function RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2022-05-31 US disclosed
EP-3672971-B1 TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE BOEHRINGER INGELHEIM INT (DE) 2021-07-14 EP disclosed
US-20210079044-A1 BIS-THIOETHER STAPLED PEPTIDES AS INHIBITORS OF PRC2 FUNCTION RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK 2021-03-18 US disclosed
US-10919953-B2 FcgammaRIIB-specific Fc region variant CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2021-02-16 US disclosed